Abstract

BackgroundThe functional aspects of mast cell-microglia interactions are important in neuroinflammation. Our previous studies have demonstrated that mast cell degranulation can directly induce microglia activation. However, the role of mast cells in Lipopolysaccharide (LPS)-induced microglia activation, neuroinflammation and cognitive impairment has not been clarified.MethodsThis study investigated the interaction between brain microglia and mast cells in vivo through site-directed injection of cromolyn into rat right hypothalamus using stereotaxic techniques. Cognitive function was subsequently assessed using trace fear conditioning and Y maze tests. Mast cells in rat brain were stained with toluidine blue and counted using Cell D software. Microglia activation was assessed by Iba1 immunohistochemistry both in rat brain and in mast cell-deficient KitW-sh/W-sh mice. Receptor expression in rat microglia was determined using flow cytometry analysis. Cytokine levels in rat brain tissue and cell supernatant were measured using high-throughput ELISA. Western blotting was used to analyze Cell signaling proteins.ResultsIn this study, intraperitoneal injection of 1 mg/kg LPS induced mast cell activation in hypothalamus and cognitive dysfunction in rats, and that this process can be repressed by the mast cell stabilizer cromolyn (200 μg). Meanwhile, in mice, LPS IP injection induced significant microglia activation 24 h later in the hypothalamus of wild-type (WT) mice, but had little effect in KitW-sh/W-sh mice. The stabilization of mast cells in rats inhibited LPS-induced microglia activation, inflammatory factors release, and the activation of MAPK, AKT, and NF-κB signaling pathways. We also found that LPS selectively provokes upregulation of H1R, H4R, PAR2, and TLR4, but downregulation of H2R and H3R, in ipsilateral hypothalamus microglia; these effects were partially inhibited by cromolyn. In addition, LPS was also found to induce activation of P815 cells in vitro, consistent with findings from in vivo experiments. These activated P815 cells also induced cytokine release from microglia, which was mediated by the MAPK signaling pathway.ConclusionTaken together, our results demonstrate that stabilization of mast cells can inhibit LPS-induced neuroinflammation and memory impairment, suggesting a novel treatment strategy for neuroinflammation-related diseases.

Highlights

  • Neuroinflammation has been recognized as the chief culprit in multiple neurodegenerative diseases

  • We demonstrate that mast cell degranulation can aggravate LPSinduced neuroinflammation by evoking microglia activation

  • To evaluate whether brain mast cells are involved in LPSinduced neuroinflammation, we determined the activation of brain mast cells in the hypothalamus at 30 min or 24 h after LPS injection

Read more

Summary

Introduction

Neuroinflammation has been recognized as the chief culprit in multiple neurodegenerative diseases. An increasing number of studies suggest that communications between microglia, immune cells, and neurons might promote the acceleration of neuroinflammation and the exacerbation of neurodegenerative disorders (Block and Hong, 2005). Emerging evidence indicates that prolonged inflammatory responses involving astrocytes and microglia promote neurodegenerative disease exacerbation (Block and Hong, 2005). Microglia switch to an activated phenotype that initiates an inflammatory response. In most cases, this response is temporary and has beneficial effects in eradicating injured CNS cells. Our previous studies have demonstrated that mast cell degranulation can directly induce microglia activation. The role of mast cells in Lipopolysaccharide (LPS)-induced microglia activation, neuroinflammation and cognitive impairment has not been clarified

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.